- Home
- CPRX vs EQC Comparison
CPRX vs EQC Comparison
Compare CPRX & EQC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- EQC
- Stock Information
- Founded
- CPRX 2002
- EQC 1986
- Country
- CPRX United States
- EQC United States
- Employees
- CPRX N/A
- EQC N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- EQC Real Estate Investment Trusts
- Sector
- CPRX Health Care
- EQC Real Estate
- Exchange
- CPRX Nasdaq
- EQC Nasdaq
- Market Cap
- CPRX 2.5B
- EQC 2.2B
- IPO Year
- CPRX 2006
- EQC 1986
- Fundamental
- Price
- CPRX $22.78
- EQC $1.70
- Analyst Decision
- CPRX Strong Buy
- EQC
- Analyst Count
- CPRX 7
- EQC 0
- Target Price
- CPRX $32.86
- EQC N/A
- AVG Volume (30 Days)
- CPRX 1.4M
- EQC 1.7M
- Earning Date
- CPRX 02-26-2025
- EQC 02-10-2025
- Dividend Yield
- CPRX N/A
- EQC N/A
- EPS Growth
- CPRX 114.68
- EQC N/A
- EPS
- CPRX 1.18
- EQC 0.38
- Revenue
- CPRX $460,482,000.00
- EQC $58,433,000.00
- Revenue This Year
- CPRX $23.98
- EQC N/A
- Revenue Next Year
- CPRX $18.27
- EQC N/A
- P/E Ratio
- CPRX $19.33
- EQC $4.42
- Revenue Growth
- CPRX 32.17
- EQC N/A
- 52 Week Low
- CPRX $13.12
- EQC $1.40
- 52 Week High
- CPRX $24.27
- EQC $21.00
- Technical
- Relative Strength Index (RSI)
- CPRX 56.81
- EQC 8.06
- Support Level
- CPRX $21.23
- EQC $1.66
- Resistance Level
- CPRX $23.26
- EQC $1.77
- Average True Range (ATR)
- CPRX 1.14
- EQC 0.06
- MACD
- CPRX 0.20
- EQC 0.63
- Stochastic Oscillator
- CPRX 74.85
- EQC 17.39
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.
About EQC Equity Commonwealth of Beneficial Interest
Equity Commonwealth is a real estate investment trust engaged in the acquisition, ownership, and operation of office buildings located throughout the United States. The vast majority of the company's real estate portfolio comprises office assets. These properties are fairly evenly dispersed between many of America's urban markets, notably Washington, Austin, and Denver. Equity Commonwealth derives the vast majority of its income in the form of rental revenue from tenants occupying its offices.